posted on 2019-09-04, 17:36authored byDevin Daems, Iene Rutten, Jonathan Bath, Deborah Decrop, Hans Van Gorp, Elena Pérez Ruiz, Steven De Feyter, Andrew J. Turberfield, Jeroen Lammertyn
The ability to detect
low concentrations of protein biomarkers
is crucial for the early-stage detection of many diseases and therefore
indispensable for improving diagnostic devices for healthcare. Here,
we demonstrate that by integrating DNA nanotechnologies like DNA origami
and aptamers, we can design innovative biosensing concepts for reproducible
and sensitive detection of specific targets. DNA origami structures
decorated with aptamers were studied as a novel tool to structure
the biosensor surface with nanoscale precision in a digital detection
bioassay, enabling control of the density, orientation, and accessibility
of the bioreceptor to optimize the interaction between target and
aptamer. DNA origami was used to control the spatial distribution
of an in-house-generated aptamer on superparamagnetic microparticles,
resulting in an origami-linked digital aptamer bioassay to detect
the main peanut antigen Ara h1 with 2-fold improved signal-to-noise
ratio and 15-fold improved limit of detection compared to a digital
bioassay without DNA origami. Moreover, the sensitivity achieved was
4 orders of magnitude higher than commercially available and literature-reported
enzyme-linked immunosorbent assay techniques. In conclusion, this
novel and innovative approach to engineer biosensing interfaces will
be of major interest to scientists and clinicians looking for new
molecular insights and ultrasensitive detection of a broad range of
targets, and, for the next generation of diagnostics.